News | March 05, 2026
PK Healthcare granted accreditation under 6th edition by NABH
The 6th Edition NABH framework places strong emphasis on patient safety protocols, robust clinical governance, risk management systems
The 6th Edition NABH framework places strong emphasis on patient safety protocols, robust clinical governance, risk management systems
This study evaluated a difficult-to-treat Crohn's disease patient population
Our clinical data suggests ProLectin-M demonstrated earlier reductions in viral shedding compared with placebo with a favorable safety profile
Ivermectin Tablets USP, 3 mg, are prescription anti-parasitic medications primarily indicated for treating parasitic worm infections in humans
Swayam is designed to support elderly patients and their families with seamless access to coordinated medical care
The TacroType test provides actionable genetic insights to help clinicians understand how individual patients metabolize tacrolimus
Asahi Kasei is consistently pursuing its strategy of building a focused, sustainable specialty pharmaceutical platform for immunocompromised and medically complex patient groups
NCFB is a chronic lung condition where damaged airways cause persistent coughing and mucus production
The NIRSE-GAL study, conducted in Galicia, Spain, is the first real-world, population-based investigation of a universal RSV immunization program spanning two consecutive seasons
The recommendation is based on new data from continuous safety monitoring of medicines in the EU
Subscribe To Our Newsletter & Stay Updated
